19F Magnetic resonance imaging of perfluorooctanoic acid encapsulated in liposome for biodistribution measurement.
The tissue distribution of perfluorooctanoic acid (PFOA), which is known to show unique biological responses, has been visualized in female mice by (19)F magnetic resonance imaging (MRI) incorporated with the recent advances in microimaging technique. The chemical shift selected fast spin-echo method was applied to acquire in vivo (19)F MR images of PFOA. The in vivo T(1) and T(2) relaxation times of PFOA were proven to be extremely short, which were 140 (+/- 20) ms and 6.3 (+/- 2.2) ms, respectively. To acquire the in vivo (19)F MR images of PFOA, it was necessary to optimize the parameters of signal selection and echo train length. The chemical shift selection was effectively performed by using the (19)F NMR signal of CF(3) group of PFOA without the signal overlapping because the chemical shift difference between the CF(3) and neighbor signals reaches to 14 kHz. The most optimal echo train length to obtain (19)F images efficiently was determined so that the maximum echo time (TE) value in the fast spin-echo sequence was comparable to the in vivo T(2) value. By optimizing these parameters, the in vivo (19)F MR image of PFOA was enabled to obtain efficiently in 12 minutes. As a result, the time course of the accumulation of PFOA into the mouse liver was clearly pursued in the (19)F MR images. Thus, it was concluded that the (19)F MRI becomes the effective method toward the future pharmacological and toxicological studies of perfluorocarboxilic acids.
Kimura
Atsuomi
A
Division of Medical Physics and Engineering, Area of Medical Technology and Science Course of Health Science, Graduate School of Medicine, Osaka University, Osaka, Japan. kimura@sahs.med.osaka-u.ac.jp
Narazaki
Michiko
M
Kanazawa
Yoko
Y
Fujiwara
Hideaki
H
D000818:Animals; D002210:Caprylates / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity; D005240:Feasibility Studies; D005260:Female; D005462:Fluorine Radioisotopes; D005466:Fluorocarbons / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity; D005753:Gastric Mucosa / Q000378:metabolism; D008081:Liposomes; D008099:Liver / Q000378:metabolism; D008279:Magnetic Resonance Imaging / Q000379:methods*; D051379:Mice; D008813:Mice, Inbred ICR; D014018:Tissue Distribution
D002210:Caprylates; D005462:Fluorine Radioisotopes; D005466:Fluorocarbons; D008081:Liposomes; C023036:perfluorooctanoic acid